ArticleBMC cancer2020

Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.